Immuron Ltd ASX: IMC OTCQB: IMROY is a microbiome company focused on developing and commercializing oral immunotherapeutics for the treatment of a many gut mediated diseases. Immuron has a unique and safe technology platform that enables a shorter development therapeutic cycle. The Company currently markets and sells Travelan for the prevention of Travelers diarrhea, whilst its lead product candidate IMM E is in Phase b clinical trials for NASH and ASH. These products together with the Company s other preclinical immunotherapy pipeline products targeting immune related diseases currently under development, will meet a large unmet need in the market.
Quote | Immuron Limited (NASDAQ:IMRN)
Last: | $2.49 |
---|---|
Change Percent: | -2.03% |
Open: | $2.51 |
Close: | $2.49 |
High: | $2.52 |
Low: | $2.43 |
Volume: | 1,273 |
Last Trade Date Time: | 04/24/2024 03:00:00 am |
News | Immuron Limited (NASDAQ:IMRN)
MELBOURNE, Australia, April 15, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to advise our Chief Executive Officer, Steven Lydeamore together with our Chief Scientific Officer, Dr. Jerry Kanello...
2024-04-10 07:07:46 ET More on Immuron Immuron surges after mid-stage data for antidiarrheal med Financial information for Immuron Read the full article on Seeking Alpha For further details see: Immuron gains after Travelan sales update
Message Board Posts | Immuron Limited (NASDAQ:IMRN)
Subject | By | Source | When |
---|---|---|---|
$IMRN good News Out running hard | knrorrel | investorshub | 05/08/2023 1:59:23 PM |
Finally something going up.. $IMRN$... | Pisd | investorshub | 05/08/2023 12:04:27 PM |
That's great news! Thanks. | subslover | investorshub | 05/08/2023 11:01:43 AM |
Immuron Announces FDA Removed Clinical Hold on New | tw0122 | investorshub | 05/08/2023 10:53:12 AM |
what do you make of this data? | THEMASTERS_SON | investorshub | 05/06/2023 11:32:56 PM |
News, Short Squeeze, Breakout and More Instantly...
Immuron Limited Company Name:
IMRN Stock Symbol:
NASDAQ Market:
MELBOURNE, Australia, April 15, 2024 (GLOBE NEWSWIRE) -- Immuron Limited ((ASX: IMC, NASDAQ:IMRN), an Australian based and globally integrated b...
MELBOURNE, Australia, April 15, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to advise our Chief Executive Officer, Steven Lydeamore together with our Chief Scientific Officer, Dr. Jerry Kanello...
Shares of Ascent Solar Technologies, Inc. (NASDAQ: ASTI) fell sharply during Wednesday’s session after the company announced pricing of a $6...